Skip to content

Optical Coherence Tomography in Patients With Acute Myocardial Infarction and Nonobstructive Coronary Artery Disease

Optical Coherence Tomography in Patients With Acute Myocardial Infarction and Nonobstructive Coronary Artery Disease: OCT and CMR Study (SOFT-MI)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02783963
Acronym
SOFT-MI
Enrollment
38
Registered
2016-05-26
Start date
2015-04-30
Completion date
2017-07-31
Last updated
2017-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myocardial Infarction

Keywords

Coronary Artery Disease, Coronary Thrombosis, Coronary Stenosis, Tomography, Optical Coherence, Magnetic Resonance Imaging

Brief summary

The purpose of this study is to evaluate the prevalence and morphological features of coronary plaques by means of OCT in patients with acute myocardial infarction but without any significant coronary stenosis at coronary angiography. In addition, cardiac magnetic resonance imaging (CMR) will be performed to assess the prevalence, location, and pattern of myocardial injury as well as other concomitant findings. As a secondary analysis, the association between the distribution and characteristics of coronary plaques detected on OCT and myocardial injury shown by CMR will be evaluated. In addition, a post-hoc survey regarding the potential modification of the interventional treatment approach based on OCT analysis will be conducted.

Detailed description

The mechanism of myocardial infarction in patients with nonobstructive coronary artery disease remains unknown. The SOFT-MI study has been designed as a single-center, prospective observational trial to investigate the prevalence of vulnerable and disrupted plaques in patients with acute MI but without any significant coronary stenosis (defined as stenosis of \>50%) at coronary angiography. All patients will undergo coronary OCT immediately after coronary angiography. In addition, CMR will be performed within 1 week of coronary angiography to evaluate associated myocardial abnormalities as well as extracardiac findings. The study will provide insight into the mechanism of MI without obstructive coronary artery disease at coronary angiography, and may be useful in order to establish an appropriate therapeutic strategy for the secondary prevention of ischemic events.

Interventions

DEVICEOCT and CMR imaging

OCT: Imaging for the presence and vulnerability of coronary plaque as well as plaque disruption. CMR: Imaging for identification of myocardial injury (late gadolinium enhancement and myocardial edema) as well as other concomitant findings.

Sponsors

National Institute of Cardiology, Warsaw, Poland
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Evidence of myocardial infarction: elevation of troponin to above the laboratory upper limit of normal (ULN) or new ST segment elevation of ≥1mm on 2 contiguous ECG leads or new left bundle branch block * Symptoms of ischaemia (chest pain or anginal equivalent symptoms at rest or new onset exertional anginal equivalent symptoms with concomitant ST-segment depression, T wave inversion or transient ST-segment elevation) * Delivery of an informed consent and compliance with study protocol * Age ≥ 18 years

Exclusion criteria

* Prior diagnosis of obstructive CAD (including history of percutaneous coronary intervention or coronary artery bypass grafting) * Stenosis \>50% of any coronary vessel on invasive angiography * Contraindication to OCT in the opinion of the treating physician * Use of vasospastic agents * Alternate causes of myocardial injury/ischaemia (severe anaemia, hypertensive crisis, acute heart failure, cardiac trauma, pulmonary embolism, etc.) * Severe renal failure (eGFR\<30) * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Prevalence of plaque disruption1 dayPrevalence of plaque disruption (including plaque rupture, plaque erosion, intracoronary thrombus) in OCT
Prevalence of myocardial injury1 weekPrevalence of late gadolinium enhancement and myocardial edema in CMR

Secondary

MeasureTime frameDescription
Prevalence of plaque vulnerability1 dayPrevalence of plaque vulnerability (including thin-cap fibroatheroma, superficial microcalcification, macrophage infiltration, and microchannel formation) in OCT
Correlation of OCT plaque characteristics and CMR findings1 week
Impact of OCT analysis on modification of interventional cardiology approach as well as medical treatment compared with coronary angiography alone (post-hoc analysis)1 week
Quantification of CAD in coronary angiography1 day

Countries

Poland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 5, 2026